AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹. Our scientists will share how small molecules and advanced research shape the future of antivirals. #AVITHRAPID #ERN2025 #Innovation

AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University. At their stand, you can learn more about our mission and the future of antiviral drug discovery. Program: www.frascatiscienza.... #AVITHRAPID #ScienceWeek #ERN2025

AI is changing healthcare 🚀 But when it comes to drug discovery, which impact do you see first? - Speed of development - Personalized therapies - Cost savings - Still unclear Cast your vote ⬇️ #AVITHRAPID #Innovation #DrugDiscovery

Our recent poll sparked a key conversation: 🧬 Vaccines prevent 💊 Antivirals treat Both are essential pillars of #globalhealth. At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.

🧪 Vaccines prevent. Antivirals treat. Both are vital — but which will shape the future of infectious disease? 🦠 Vaccines Antivirals Both equally Not sure 👉 Vote in the poll and share your thoughts in the comments! Your perspective matters for the future of global health.

AVITHRAPID and Area Science Park just published an annoucement about their new partnership to drive antiviral and preventive innovation. The MoU strengthens Europe’s scientific response to future health threats. 📰 Read more: avithrapid.eu/avithr... #AVITHRAPID #ScienceFeed #PublicHealth #Innovation

AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you. Subscribe to our newsletter for updates on research, events, partnerships & more. 📩 avithrapid.eu/newsle... #AVITHRAPID #ScienceFeed #PublicHealth

Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science

It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs. At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact. #ScienceFeed #HealthEquity

Who’s behind AVITHRAPID? A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.

From hepatitis C to tomorrow’s viruses: AVITHRAPID builds on proven science to prepare for future outbreaks. #WorldHepatitisDay #ScienceFeed

AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics. The partnership will boost rapid antiviral development, training, funding strategy & long-term impact. #AVITHRAPID #ScienceFeed #PandemicResponse

What’s next for AVITHRAPID? Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds. Stronger preparedness through innovation. #AVITHRAPID #PandemicPreparedness #OneHealth

🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄 📸 Highlights below! #HorizonEU #DrugRepurposing #PandemicPreparedness

🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄 📸 Highlights below! #HorizonEU #DrugRepurposing #PandemicPreparedness

Neglected tropical diseases (NTDs) affect over 1.5 billion people worldwide, yet treatment options remain limited. Broad-spectrum antivirals offer a promising solution. Let’s push for innovation and progress. Stay informed on the latest updates—subscribe to our newsletter at www.avithrapid.eu

Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation

Market gaps in broad-spectrum #antivirals are clear: limited #discovery platforms, resistance concerns, clinical trial barriers, and access issues. It’s time to bridge these gaps and innovate to protect global health. Subscribe to our newsletter: www.avithrapid.eu#antivirals

The world isn’t short on brilliant science. It’s short on collaboration, clarity, and courage. In the face of the next crisis, how we organize knowledge may matter more than how we generate it. We can’t afford siloed thinking anymore. #AVITHRAPID

Meet Paulo da Silva, R&D Specialist at @IT4Innovations 🇨🇿 & key partner in #AVITHRAPID. With HPC expertise, Paulo drives the in-silico engines accelerating antiviral discovery. 🧬💻 🎥 Watch the video & see how supercomputing helps fight pandemics! #DrugDiscovery #HPC #PandemicPreparedness

🔬 AVITHRAPID's Latest Discovery: Halicin Targets SARS-CoV-2 3CLpro. Our new study reveals that halicin binds to both Cys145 and Cys44 in 3CLpro, disrupting its function and stability. This dual targeting offers a promising avenue for broad-spectrum antiviral development www.sciencedirect.co...

AVITHRAPID was showcased at #AREVIR2025 in Cologne! Francesca Incardona presented our mission to a hybrid audience of 120+ experts in infectious diseases, virology & AI. Thanks to the organizers for the spotlight! 🌐 www.avithrapid.eu#AREVIR2025#HorizonEU #OneHealth

🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)! Harnessing Computational Power – Presented by Carmine Talarico 💻 AVITHRAPID’s in silico pipeline for antiviral targets 🧬 Applied to Dengue virus 🔍 Public workflows, docking & MD-ready models 📂 Fully open-access

🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)! PLpro Inhibitors Poster – Presented by Antonietta Mollo ✔️ 7 validated molecular clusters ✔️ Hits in µM IC50 range ✔️ No toxicity, modest antiviral activity ✔️ X-ray co-crystallization & SAR studies ongoing

Meet the AVITHRAPID Consortium 🧪🔬 How are antiviral compounds screened and optimized? Francesca Esposito, Associate Professor at Università degli Studi di Cagliari, is developing biochemical assays to identify and refine antiviral inhibitors. 🎥 Watch the short video to learn more!

📈 The Future of Antivirals is Here From AI-powered drug discovery to real-world clinical trials, we’re rewriting the rules of antiviral development. Don’t miss out! avithrapid.eu/newsle...

📢 Hear from the Experts Exclusive interviews with scientists, researchers, and leaders in the field—only in our newsletter! 🎙️ avithrapid.eu/newsle...

🤝 Power in Collaboration AVITHRAPID brings together top scientists, pharmaceutical innovators, and data experts. Stay connected to global innovation! 🌍 avithrapid.eu/newsle...

💊 New Treatments for Emerging Viruses Zika, SARS-CoV-2, and beyond—we’re tackling viruses with epidemic potential. Want in? Subscribe! 🦠📩 avithrapid.eu/newsle...

🔬 From Lab to Life-Saving Drugs Every breakthrough starts in the lab. Get early access to our discoveries and impact on global health. 🏥🔬 avithrapid.eu/newsle...

🎯 Pandemic-Ready Innovation We’re creating broad-spectrum antivirals to prepare for the next “Disease X.” Stay ahead of the curve—sign up now! 📩 avithrapid.eu/newsle...

🧬 From Molecule to Medicine Discover how we turn promising molecules into powerful antiviral treatments—straight to your inbox! 💊✨ avithrapid.eu/newsle...

📡 Open Science, Open Future Our data follows FAIR principles (Findable, Accessible, Interoperable, Reusable) for maximum impact. Get the latest discoveries first! 🚀 avithrapid.eu/newsle...

🌎 Global Protection, One Antiviral at a Time The fight against pandemics starts before they begin. Follow our journey! 🛡️📢 avithrapid.eu/newsle...

🚀 AVITHRAPID SEMINARS are here! Kicking off with a closed-door session on March 3 with HERA (DG SANTE) on antiviral strategies. 🔹 Stay tuned for next seminars in weeks 📩 Do you want to make a presentation to the next seminar ? Contact [email protected]

💡 AI-Powered Drug Discovery We use machine learning and computational modeling to develop next-gen antiviral treatments. Want to know how? Subscribe! 🤖📈 avithrapid.eu/newsle...

🔍 Science in Action! AVITHRAPID unites 18 top research institutions across 8 countries to revolutionize antiviral drug development. Get exclusive updates! 🌍🔗 avithrapid.eu/newsle...

⚡ Speed is Everything! Our research is designed to turn small molecules into life-saving treatments—faster than ever before. Be the first to know how we do it! 🏃‍♂️💊 avithrapid.eu/newsle...

💡 A Call for Action! Fighting pandemics needs regulatory approval, pharma expertise & policy backing. We’re building broad-spectrum antivirals—will you join us? 🤝 📩 Let’s talk! https://avithrapid.eu/ #AVITHRAPID #PublicHealth #PandemicStrategy

🦠 A World Without Pandemics? AVITHRAPID is building a fast-response antiviral pipeline to stop future outbreaks. Stay informed—sign up now! avithrapid.eu/newsle...

🌍 Ready for the Next Pandemic? Pandemic threats demand global action! We’re calling on regulators, pharma, governments & public health leaders to accelerate antiviral innovation. Will you join us? 🤝 Let’s shape the future together! 📩 DM us to collaborate! https://avithrapid.eu/

🚀 Meet AVITHRAPID! A cutting-edge European research initiative developing broad-spectrum antiviral drugs to combat pandemics. Join us as we revolutionize antiviral therapy! 🦠💊 https://avithrapid.eu/ #AVITHRAPID #PandemicPreparedness

🧬 Extracellular Vesicles & Their Role in Biomedicine 🧬 📅 12 Feb 2025 9am CET | 🏛 UniTuscia, Italy Learn how mEVs are transforming molecular delivery also in #AVITHRAPID! 📡 Enter the event visiting www.unitus.it/wp-con...#AVITHRAPID!

We are proud members of the #Avithrapid consortium @avithrapid.bsky.social From basic science to clinical assays, aiming to develop broad spectrum #antivirals.

Researchers are racing to develop broad-spectrum antivirals to defend us from emerging threats. Discover how #AVITHRAPID is shaping the next gen of treatments for a healthier world! avithrapid.eu/newsle... Credit image: doi.org/10.3390/trop...#AVITHRAPID#Antivirals #GlobalHealth

🦠 Which virus could cause next pandemic? What worries you most? 🔹 New coronaviruses (zoonotic spillover) 🔹 Re-emerging viruses (i.e. Zika, Dengue) 🔹 Antiviral resistance (mutation risks) 🔹 Disease X (unknown future pathogen) 🗳 Let's discuss #FuturePandemics #OneHealth #AntiviralResearch

📅 2024 Year of Innovation at AVITHRAPID! Over the past months, we’ve explored: 🔹 The need for broad-spectrum antivirals 🔹 Disease X & pandemic preparedness 🔹 AI & drug repurposing 💡 www.avithrapid.eu #ScienceCommunity #Innovation #FutureHealth

🌍 Are we ready for the next pandemic? HERA highlight the need for broad-spectrum antivirals to boost preparedness. ⚠ Lessons from COVID-19: we must act before the next outbreak, not after. 🔬 Are we doing enough? 🔗 Read more: health.ec.europa.eu/... #OneHealth #PandemicPreparedness #Antivirals

🎥 Discover Avithrapid's Mission & Workflow! 👀 Watch our video detailing our project goals and the steps we're taking to combat pandemics. Dive into our world of groundbreaking research and see how we're shaping the future of healthcare! youtu.be/HWZVAZJXLtU?...

🌟 Stay Ahead with Avithrapid! 🔗 Dive deeper into our world by visiting our website! Sign up for our newsletter to stay updated on publications, events, and much more. 📬 Join our community today and be part of the future of healthcare solutions! avithrapid.eu/newsletter/